Federal Register #2026-20943

DEA Notice on Proposed Temporary Schedule I Controls for Two Kratom-Related Substances

The Drug Enforcement Administration (DEA) is considering temporary Schedule I controls for two kratom-related substances under the Controlled Substances Act. - Government agency: DEA, within the U.S. Department of Justice; the Department of Health and Human Services (HHS) recommended the threshold. - Substances covered: 7-hydroxymitragynine and mitragynine pseudoindoxyl when either substance individually, or their combined amount when both are present, exceeds a specified threshold. The supplied notice summary does not state the numeric threshold. - Scope of controls: The proposed controls would also cover applicable isomers, esters, ethers, salts, and related salts. Schedule I controls and associated administrative, civil, and criminal sanctions would apply to covered handling activities. - Safety caveat: Neither HHS nor DEA has determined that amounts below the threshold are safe. - Procurement status: This is a regulatory notice, not a procurement or contract award. No products, services, quantities, part numbers, OEMs, or vendors are identified.

Description

The Drug Enforcement Administration (DEA) issued a notice of intent to publish a temporary order placing 7-hydroxymitragynine and mitragynine pseudoindoxyl in Schedule I of the Controlled Substances Act when either substance alone, or their combined amount when both are present, exceeds a specified threshold. The placement would also cover their isomers, esters, ethers, salts, and related salts where those forms are possible. If the temporary order is issued, Schedule I controls and related administrative, civil, and criminal sanctions would apply to persons handling or proposing to handle the substances above the threshold. The source states that neither HHS nor DEA has found below-threshold levels safe to use.

View original listing